Evidence map›Paper›PMID 32989599›Full record

ReviewWorld journal of microbiology & biotechnology2020

Extracellular polysaccharides produced by bacteria of the Leuconostoc genus.

Peteris Zikmanis, Karlis Brants, Sergejs Kolesovs, Pavels Semjonovs

Abstract readReview
PubMed Publisher
In one paragraph

Review in World journal of microbiology & biotechnology, 2020. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 17 papers.

0numbers the graph read from it
0cells of the map it votes in
17citing papers in PubMed
3.6field-weighted citation impact, top 6% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

17 citing papers in PubMed, 54 citations in OpenAlex.

  1. Trial
  2. Review
  3. Article
  4. Article
  5. Article
  6. Article
  7. Review
  8. Review
  9. Article
  10. Screening of exopolysaccharide-producingFrontiers in microbiology · 2023
    Article
  11. Review
  12. Article
  13. Comparative genome analysis of fourComputational and structural biotechnology journal · 2022
    Article
  14. Article
  15. Review
  16. Article
  17. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

4 authors at 1 institution in 1 country.

Peteris ZikmanisLaboratory of Industrial Microbiology and Food Biotechnology, Institute of Biology, University of Latvia, Ojara Vaciesa str. 4, Riga, 1004, Latvia.
Karlis BrantsProbiotika LV, Ltd, Brivibas gatve 451, Riga, 1024, Latvia.
Sergejs KolesovsLaboratory of Industrial Microbiology and Food Biotechnology, Institute of Biology, University of Latvia, Ojara Vaciesa str. 4, Riga, 1004, Latvia.
Pavels SemjonovsLaboratory of Industrial Microbiology and Food Biotechnology, Institute of Biology, University of Latvia, Ojara Vaciesa str. 4, Riga, 1004, Latvia. pavels.semjonovs@lu.lv.ORCID http://orcid.org/0000-0002-6943-4697
University of Latvia · LV

Funding

Ministry of Agriculture and Rural Support Service of the Republic of Latvia 19-00-A01612-000004
6 · The paper itself

Abstract

Structurally diverse biopolymers, including extracellular polysaccharides (EPS), synthesized by bacteria can possess physicochemical and functional properties that make them important products of microbial synthesis with a broad and versatile biotechnological potential. Leuconostoc spp. belongs to the group of lactic acid bacteria as one of the predominant members and are relevant not only in varied food fermentations, but also can be employed in the production of extracellular homopolysaccharides (HoPS) such as α-glucans (dextran, alternan) and β-fructans (levan,inulin) from the sucrose-containing substrates. EPS are synthesized by specific Leuconostoc spp. extracellular glycosyltransferases [dextran sucrase, alternansucrase (ASR)] and fructosyltransferases (levansucrase, inulosucrase) and enzymatic reactions can be performed in whole culture systems as well as using cell-free enzymes. Both α-glucans and β-fructans have a wide range of properties, mostly depending on their pattern of linkages, which, although differing in some respects, make suitable prerequisites for their versatile application in many fields, especially in the food industry and biomedicine. As a rule, these properties (polymer type, molecular mass, rheological parameters), as well as the overall EPS yield, are strain-specific for the selected producers and depend to a large extent on the nutritional and growth conditions used, which in many cases remain not sufficiently optimized for Leuconostoc spp. This review summarizes the current knowledge on the potential of Leuconostoc spp. to produce commercially relevant EPS, including information on their applications in various fields, producer strains, production methods and techniques used, selected conditions, the productivity of bioprocesses as well as the possible use of renewable resources for their development.

Indexed as

Antigens, T-IndependentDextransFructansGlucansGlycosyltransferasesInulinLeuconostocMolecular WeightPolysaccharides, BacterialSucraseSucrosealternansucraseAntigens, T-IndependentDextransFructansGlucansGlycosyltransferasesInulinlevanPolysaccharides, BacterialSucraseSucroseAlternanDextranExopolysaccharidesInulinLeuconostoc spp.Levan

Identifiers

PMID32989599
OpenAlexW3091293570

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.